OnKure Therapeutics, Inc. (OKUR) Total Assets by Year
OnKure Therapeutics, Inc. closed fiscal year 2025 with $62.1M in total assets, $5.9M in total liabilities and $56.2M in shareholder equity. This represents a decrease of 45.9% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters OnKure Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
OKUR Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K |
|---|---|---|---|---|---|---|
| Total Assets | $62.1M-45.9% | $114.9M+221.6% | $35.7M-67.0% | $108.2M-29.8% | $154.0M+178.9% | $55.2M |
| Total Liabilities | $5.9M-46.4% | $11.1M-91.9% | $137.6M-15.4% | $162.6M+2286.6% | $6.8M-93.0% | $97.3M |
| Total Equity | $56.2M-45.9% | $103.8M+202.0% | -$101.8M-87.1% | -$54.4M-137.0% | $147.2M+449.5% | -$42.1M |
OKUR Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-Q | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $179.4M+108.4% | $198.7M+98.9% | $62.1M-45.9% | $72.8M-6.2% | $86.1M+9.3% | $99.9M+18.0% | $114.9M+221.6% | $77.6M-40.5% | $78.7M-46.8% | $84.6M-14.4% | $35.7M-67.0% | $130.4M+6.4% |
| Total Liabilities | $7.2M-8.3% | $14.3M+55.3% | $5.9M-46.4% | $6.4M-97.0% | $7.9M-96.1% | $9.2M-95.3% | $11.1M-91.9% | $212.7M+1277.2% | $202.3M+1204.2% | $195.9M+1562.4% | $137.6M-15.4% | $15.4M+47.7% |
| Total Equity | $172.1M+120.2% | $184.4M+103.4% | $56.2M-45.9% | $66.4M+149.2% | $78.2M+163.3% | $90.6M+181.5% | $103.8M+202.0% | -$135.1M-217.5% | -$123.6M-193.2% | -$111.3M-227.8% | -$101.8M-87.1% | $114.9M+2.6% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More OnKure Therapeutics, Inc. financials
Frequently Asked Questions
What was OnKure Therapeutics, Inc.'s total assets in fiscal year 2025?
OnKure Therapeutics, Inc. closed fiscal year 2025 with $62.1M in total assets, $5.9M in total liabilities and $56.2M in shareholder equity.
How fast is OnKure Therapeutics, Inc.'s total assets growing?
OnKure Therapeutics, Inc. (OKUR) total assets fell by 45.9% year over year, from $114.9M to $62.1M in fiscal year 2025.
How has OnKure Therapeutics, Inc.'s total assets changed over the years?
Across the 6 fiscal years this page covers, OnKure Therapeutics, Inc. (OKUR) total assets went from $55.2M in fiscal year 2020 to $62.1M in fiscal year 2025.
What was OnKure Therapeutics, Inc.'s total assets in the most recent quarter?
OnKure Therapeutics, Inc. (OKUR) reported $179.4M in total assets in Q2 2026. This represents an increase of 108.4% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what OnKure Therapeutics, Inc. (OKUR) reported on that line in every period on record.